Trials / Unknown
UnknownNCT01455610
Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study
Preoperative Evaluation of Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 140 (estimated)
- Sponsor
- Meng Su Zeng · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this multicenter and double-blind clinical trial is to prospectively assess the sensitivity, specificity, negative predictive value, positive predictive value, and accuracy in respectability of pancreatic head cancer with contrasted-enhanced MDCT and its various post processing techniques, taking operational and pathological records as the gold standard.
Conditions
Timeline
- Start date
- 2011-10-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2011-10-20
- Last updated
- 2011-10-20
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01455610. Inclusion in this directory is not an endorsement.